bioRxivPharmacology & ToxicologyPreprint
A 3-Dimensional bioprinted human gut-liver axis model for studying Alcoholic Liver Disease
K. Meher, M. Rottela, S. K, S. Iyer, G. Kadiyala, S. Vangala, S. Chandran, U. Saxena
Abstract
Gut-liver axis is the interaction between the gut, its microbiome and the liver. The crosstalk and interaction between these organs plays an important role in their individual health and disease. Alcoholic liver disease (ALD) is a case in point where dysfunction of intestine actively promotes liver damage by alcohol. A flashpoint in ALD is the breach of intestinal integrity caused by gut bacteria Enterococcus faecalis (E.Faecalis). More specifically, Cytolysin, a toxin secreted by this bacteria may have a central role in the genesis of ALD. 3-D bioprinted human simulations of the gut-liver axis may help better understand the genesis of ALD. Here we developed a 3 dimensional bioprinted in vitro model composed of human origin intestinal and liver cells to explore the role of Cytolysin and ethanol in intestinal and liver damage. We find that neither Cytolysin or ethanol are sufficient for cell damage but a combination of the two act in concert to cause maximum breach in intestinal integrity. Secondly we find that enhanced transport of macromolecules thru the intestinal layer is not caused by overt cell toxicity but occurs through potentially paracellular/transcellular pathways. Our model will be used to test repurposed and new drugs/ biologics for treatment of ALD as well as other intestinal inflammatory diseases.
- organism: human
- assay: organoid / primary culture
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling alcoholic liver disease in a human Liver-Chip
J. C. Nawroth, D. B. Petropolis, … K. Karalis·bioRxiv·Jul 14, 2020
- A Triple-Hit Alcoholic Liver Disease Model Linking High-Fat Diet, Endotoxins, and Neo-Antigen Formation
Shivani Arora, Anju Bansal, Anju Katyal·bioRxiv·Nov 10, 2025
- Flavor compounds in fermented Chinese alcoholic beverage alter gut microbiota and attenuate ethanol-induced liver
Cheng Fang, Hai Du, … Yan Xu·bioRxiv·Oct 8, 2018
- Patient-derived liver biopsy organoids enable precision alcohol-associated liver disease modeling
Sílvia Ariño, Laura Zanatto, … Pau Sancho‐Bru·bioRxiv·Mar 22, 2025
- Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease
J. Yang, Y. Hirai, … K.-i. Kamei·bioRxiv·Jun 10, 2020
- Development of alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell derived liver organoids